[1] Elhendy A, Bax JJ, Poldermans D. Dobutamine Stress Myocardial Perfusion Imaging in Coronary Artery Disease[J]. J Nucl Med, 2002, 43(12):1634-1646.
[2] Sharir T, Germano G, Kang XP, et al. Prediction of myocardial infarction versus cardiac death by gated myocardial perfusion SPECT:Risk stratification by the Amount of Stress-Induced Ischemia and the Poststress Ejection Fraction[J]. J Nucl Med, 2001, 42(6):831-837.
[3] Pitt B, Water D, Brown WV, et al. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease:atorvastatin versus revasularization treatment investigators[J]. N Engl J Med, 1999, 341(8):70-76.
[4] Sharir T, Germano G, Kavanagh PB, et al. Incremental prognostic value of poststress left ventricular ejection fraction and volume by gated myocardial perfusion single photon emission computed tomography[J]. Circulation, 1999,100(9):1035-1042.
[5] Germano G, Kavanagh PB, Chen J, et al. Operator-Jess processing of myocardial perfusion SPECT studies[J]. J Nucl Med, 1995, 36(11):2127-2132.
[6] Hachemovitch R, Berman DS, Shaw LJ, et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death:differential stratification for risk of cardiac death and myocardial infarction[J].Circulation, 1998,97(2):535-543.
[7] Ambrose JA, Tannenbaum MA, Alexopoulos D, et al. Angiographic progression of coronary artery disease and the development of myocardial infarction[J]. J Am Coll Cardiol, 1998, 12(1):56-62.
[8] Shah PK. Plaque size, vessel size and plaque vulnerability:higger may not be better[J]. J Am Coll Cardiol, 1998,32(9):663-664.
[9] Johnson LL, Verdesca SA, Aude WY, et al. Postischemic stunning can affect left ventricular ejection fraction and regional wall motion on post-stress gated sestamibi tomograms[J]. J Am Coll Cardiol, 1997, 30(7):1641-1648.
[10] Bavelaar-Croon CDL, Atsma DE, Wall VDEE, et al. The additive value of gated SPET myocardial perfusion imaging in patients with known and suspected coronary artery disease[J]. J Nucl Med, 2001, 22(1):45-55.
[11] Yusuf S, Zucker D, Peduzzi P, et al. Effect of coronary artery bypass graft surgery on survival:overview of 10-years results from randomized trials by the Coronary Artery Bypass Graft Surgery T rialists Collaboration[J].Lancet, 1994, 344(8922):563-570.
[12] RITA-2 trial participants. Coronary angioplasty versus medical therapy for angina:The Second Randomized Intervention Treatment of Angina (RITA-2) trial[J]. Lancet,1997, 350(9076):461-468.
[13] Dakik HA, Mahmarian JJ, Kimball KT, et al. Prognostic value of exercise 201Tl tomography in patients treated with thrombolytic therapy during acute myocardial infarction[J].Circulation, 1996, 94(12):2735-2742.
[14] Angeja BG, Gunda M, Murphy SA, et al. TIMI myocardial perfusion grade and ST segment resolution:Association with infarct size as assessed by single photon emission computed tomography imaging[J]. Circulation, 2002, 105(1):282-285.
[15] Giri S, Shaw LJ, Murthy DR, et al. Impact of diabetes on the risk stratification using stress single-photon emission computed tomography myocardial perfusion imaging in patients with symptoms suggestive of coronary artery disease[J]. Circulation, 2002(1),105:32-40.
[16] Miller DD, Stratmann HG, Shaw L, et al. Dipyridamole technetium 99m sestamibi myocardial tomography as an independent predictor of cardiac event-free survival after acute ischemic events[J]. J Nucl Cardiol, 1994, 1(1):72-82.
[17] Stratmann HG, Younis LT, Wittry MD, et al. Dipyridamole technetium 99m sestamibi myocardial tomography for preoperative cardiac risk stratification before major or minor nonvascular surgery[J]. Am Heart J, 1996, 132(3):536-541.